Multiple chemical scaffolds inhibit a promising Leishmania drug target

Multiple chemical scaffolds inhibit a promising Leishmania drug target

Bibliographic Details
Main Author:	Malcolm Walkinshaw
Format:	Article
Language:	English
Published:	International Union of Crystallography 2014-07-01
Series:	IUCrJ
Subjects:	N-myristoyltransferase inhibitor ligand binding Leishmania drug discovery
Online Access:	http://scripts.iucr.org/cgi-bin/paper?S2052252514014572

Similar Items

N-Myristoyltransferases as antileishmanial targets: a piggyback approach with benzoheterocyclic analogues
by: Luis Otávio Junqueira, et al.
Published: (2019-10-01)

Novel Hits for N-Myristoyltransferase Inhibition Discovered by Docking-Based Screening
by: Danislav S. Spassov, et al.
Published: (2022-08-01)

Target engagement and binding mode of an antituberculosis drug to its bacterial target deciphered in whole living cells by NMR
by: Bouvier, Guillaume, et al.
Published: (2021)

The role of N-myristoyltransferase 1 in tumour development
by: Hong Wang, et al.
Published: (2023-12-01)

N-Myristoyltransferase, a Potential Antifungal Candidate Drug-Target for Aspergillus flavus
by: Yu Wang, et al.
Published: (2023-02-01)

Analyzing a potential drug target N-myristoyltransferase of Plasmodium falciparum through in silico approaches
by: Amit Kumar Banerjee, et al.
Published: (2012-01-01)

Role of Leishmania (Leishmania) amazonensis amastigote glycosphingolipids in macrophage infectivity
by: A.K. Tanaka, et al.
Published: (2007-06-01)

Target-based vs. phenotypic screenings in Leishmania drug discovery: A marriage of convenience or a dialogue of the deaf?
by: Rosa M. Reguera, et al.
Published: (2014-12-01)

Association of NMT2 with the acyl-CoA carrier ACBD6 protects the N-myristoyltransferase reaction from palmitoyl-CoA[S]
by: Eric Soupene, et al.
Published: (2016-02-01)

Discovery of Leishmania Druggable Serine Proteases by Activity-Based Protein Profiling
by: Exequiel O. J. Porta, et al.
Published: (2022-07-01)

Inhibitor Trapping in N-Myristoyltransferases as a Mechanism for Drug Potency
by: Danislav S. Spassov, et al.
Published: (2023-07-01)

Inhibition of N‐myristoyltransferase1 affects dengue virus replication
by: San Suwanmanee, et al.
Published: (2019-09-01)

Naphthoquinone as a New Chemical Scaffold for Leishmanicidal Inhibitors of <i>Leishmania</i> GSK-3
by: Victor Sebastián-Pérez, et al.
Published: (2022-05-01)

Identification of Potential <i>Leishmania</i> N-Myristoyltransferase Inhibitors from <i>Withania somnifera</i> (L.) Dunal: A Molecular Docking and Molecular Dynamics Investigation
by: Mohamed A. A. Orabi, et al.
Published: (2023-01-01)

On Leishmania enriettii and Other Enigmatic Leishmania Species of the Neotropics
by: Ralph Lainson
Published: (1997-05-01)

Dynamic Docking: A Paradigm Shift in Computational Drug Discovery
by: Dario Gioia, et al.
Published: (2017-11-01)

Phosphatidylcholine-Specific Phospholipase C as a Promising Drug Target
by: Chatchakorn Eurtivong, et al.
Published: (2023-07-01)

The Potential Use of N-Myristoyltransferase as a Biomarker in the Early Diagnosis of Colon Cancer
by: Rajendra K Sharma, et al.
Published: (2011-03-01)

A Personal History of Using Crystals and Crystallography to Understand Biology and Advanced Drug Discovery
by: Tom L. Blundell
Published: (2020-08-01)

Towards discovery of new leishmanicidal scaffolds able to inhibit Leishmania GSK-3
by: Paula Martínez de Iturrate, et al.
Published: (2020-01-01)

The activity of azithromycin against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the golden hamster model A atividade da azitromicina contra a Leishmania (Viannia) braziliensis e a Leishmania (Leishmania) amazonensis no modelo golden hamster
by: Ángel Sinagra, et al.
Published: (2007-12-01)

Aurapten, a coumarin with growth inhibition against Leishmania major promastigotes
by: Napolitano H.B., et al.
Published: (2004-01-01)

Overview of the organization of protease genes in the genome of Leishmania spp
by: Mariana Silva-Almeida, et al.
Published: (2014-08-01)

Novel, First-in-Human, Oral PCLX-001 Treatment in a Patient with Relapsed Diffuse Large B-Cell Lymphoma
by: Randeep Sangha, et al.
Published: (2022-03-01)

Monoclonal antibodies for the identification of New World Leishmania species
by: Gabriel Grimaldi Jr, et al.
Published: (1996-02-01)

High Content Analysis of Macrophage-Targeting <i>Eh</i>PIb-Compounds against Cutaneous and Visceral <i>Leishmania</i> Species
by: Helena Fehling, et al.
Published: (2021-02-01)

QSAR Study of N-Myristoyltransferase Inhibitors of Antimalarial Agents
by: Letícia Santos-Garcia, et al.
Published: (2018-09-01)

"DIFERENTIAION OF LEISHMANIA TROPICA MAJOR FROM LEISHMANIA TROPICA MINOR BY INOCULATION TO LABORATORY ANIMALS "
by: A.Nadim, et al.
Published: (1973-06-01)

Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors
by: Xile Zhou, et al.
Published: (2023-04-01)

Subcellular localization studies of LdBPK_070020, a conserved protein of Leishmania donovani
by: Ruchika Bhardwaj, et al.
Published: (2016-01-01)

Effect of phospholipase A2 inhibitors during infection caused by Leishmania (Leishmania) amazonensis
by: Maria L. A. C. Bordon, et al.
Published: (2018-08-01)

Development of Leishmania (Mundinia) in guinea pigs
by: Tomas Becvar, et al.
Published: (2020-04-01)

<i>In Vitro</i> Drug Susceptibility of a <i>Leishmania (Leishmania) infantum</i> Isolate from a Visceral Leishmaniasis Pediatric Patient after Multiple Relapses
by: Bianca A. Ferreira, et al.
Published: (2023-07-01)

Discovery of Novel Myristic Acid Derivatives as N-Myristoyltransferase Inhibitors: Design, Synthesis, Analysis, Computational Studies and Antifungal Activity
by: Saleem Javid, et al.
Published: (2023-07-01)

Antileishmanial effects of Crotalaria spectabilis Roth aqueous extracts on Leishmania amazonensis
by: JULIANA S. PACHECO, et al.
Published: (2023-09-01)

immune response in human leishmania infections Respuesta inmune en infecciones humanas por Leishmania spp
by: Sara María Robledo Restrepo, et al.
Published: (2000-03-01)

Targeting STAT-3 signaling pathway in cancer for development of novel drugs: Advancements and challenges
by: Sundas Arshad, et al.
Published: (2020-02-01)

Ocular alterations in dogs naturally infected by Leishmania (Leishmania) chagasi Alterações oculares em cães infectados naturalmente por Leishmania (Leishmania) chagasi
by: F.L.C. Brito, et al.
Published: (2006-10-01)

Fatty Acid Composition and Metabolism in <i>Leishmania</i> Parasite Species: Potential Biomarkers or Drug Targets for Leishmaniasis?
by: Marine Leroux, et al.
Published: (2023-02-01)

LEİSHMANİA HEPATİTLİ BİR OLGU
by: Ayşe Selimoğlu, et al.
Published: (2020-09-01)